The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, Pediatrix Medical Group Inc’s stock clocked out at $12.57, down -2.10% from its previous closing price of $12.84. In other words, the price has decreased by -$2.10 from its previous closing price. On the day, 0.54 million shares were traded. MD stock price reached its highest trading level at $12.84 during the session, while it also had its lowest trading level at $12.48.
Ratios:
To gain a deeper understanding of MD’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.93 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 5.56. For the most recent quarter (mrq), Quick Ratio is recorded 1.81 and its Current Ratio is at 1.81. In the meantime, Its Debt-to-Equity ratio is 0.83 whereas as Long-Term Debt/Eq ratio is at 0.79.
On September 26, 2024, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $8 to $14.
Deutsche Bank Upgraded its Sell to Hold on June 07, 2024, while the target price for the stock was maintained at $8.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 21 ’25 when Swift James D bought 18,530 shares for $16.63 per share.
ORDAN MARK S sold 27,600 shares of MD for $423,660 on Nov 13 ’24. The Director now owns 138,683 shares after completing the transaction at $15.35 per share. On Nov 13 ’24, another insider, ORDAN MARK S, who serves as the Director of the company, bought 27,600 shares for $15.50 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MD now has a Market Capitalization of 1079834624 and an Enterprise Value of 1644545920. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.55 while its Price-to-Book (P/B) ratio in mrq is 1.37. Its current Enterprise Value per Revenue stands at 0.832 whereas that against EBITDA is 7.3.
Stock Price History:
The Beta on a monthly basis for MD is 1.22, which has changed by 0.6431372 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, MD has reached a high of $17.67, while it has fallen to a 52-week low of $7.40. The 50-Day Moving Average of the stock is -9.47%, while the 200-Day Moving Average is calculated to be -9.27%.
Shares Statistics:
It appears that MD traded 857.12K shares on average per day over the past three months and 571810 shares per day over the past ten days. A total of 85.81M shares are outstanding, with a floating share count of 84.40M. Insiders hold about 1.76% of the company’s shares, while institutions hold 88.76% stake in the company. Shares short for MD as of 1749772800 were 2178973 with a Short Ratio of 2.72, compared to 1747267200 on 1393134. Therefore, it implies a Short% of Shares Outstanding of 2178973 and a Short% of Float of 3.56.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
